-
Clinical Challenges When NSCLC Histologically Transforms Into SCLC
29 Jan 2025 22:14 GMT
… non-small cell lung cancer (NSCLC) … lung cancer (SCLC), a histologically distinct subtype of lung cancer,” … histologically distinct subtypes — small cell lung cancer (SCLC) or non-small cell lung cancer … Resistance to Targeted Lung Cancer Therapies: Emerging …
-
Sex-based differences in lung cancer
25 Jan 2025 01:05 GMT
… the emergence and progression of lung tumors. Estrogen receptor (ER) expression, particularly … longer view lung cancer as a monolith. Even within specific histological subtypes, the …
-
Kim Evaluates New Regimens for EGFR+ Lung Cancer
20 Jan 2025 15:28 GMT
… had nonsquamous disease] but mixed histology was allowed. They were newly … -mutated, advanced non-small cell lung cancer (NSCLC): primary results from MARIPOSA …
-
Effects of Tp53 Gene Mutations on the Survival of Non-Small Cell Lung Cancer (NSCLC); A Short Review
15 Jan 2025 11:59 GMT
… lung cancer: non-small cell lung cancer (NSCLC) and small cell lung cancer … Finnish non-small cell lung cancers. Lung Cancer. 2016;99:102 … non-small-cell lung cancer. Lung Cancer. 2018;123:22 … EGFR-mutant lung cancers at risk for histologic transformation …
-
AstraZeneca-Daiichi Sankyo Datopotamab deruxtecan gets USFDA priority review in pretreated EGFR-mutated non-small cell lung cancer
14 Jan 2025 09:58 GMT
… mutated non-small cell lung cancer presents a significant … antibody drug conjugate for lung cancer, providing a promising … million lung cancer cases were diagnosed globally in 2022. Lung cancer is … in tumours of nonsquamous histology.
For patients with tumours …
-
Datopotamab deruxtecan granted Priority Review in the US for patients with previously treated advanced EGFR-mutated non-small cell lung cancer
13 Jan 2025 12:20 GMT
… small cell lung cancer
Nearly 2.5 million lung cancer cases … in tumors of nonsquamous histology.6
For patients … breast cancer, small cell lung cancer, urothelial, gastric, pancreatic, … improvements for people with lung cancer, including and beyond treatment …
-
Datopotamab Deruxtecan Granted Priority Review in the U.S. for Patients with Previously Treated Advanced EGFR-Mutated Non-Small Cell Lung Cancer
13 Jan 2025 07:07 GMT
… antibody drug conjugate for lung cancer, providing a promising … breast cancer, small cell lung cancer, urothelial, gastric, pancreatic, … Small Cell Lung Cancer
Nearly 2.5 million lung cancer cases were … in tumors of nonsquamous histology.5
For patients with …
-
Gut Microbiome and Metabolite Characteristics Associated With Different Clinical Stages in Non-Small Cell Lung Cancer Patients
10 Jan 2025 18:09 GMT
… intestinal metabolites affecting lung cancer progression as primarily … results. 5) Additional histological and blood samples of … for the study of lung cancer lung cancer staging project: proposals … biomarkers for lung cancer[J]. Transl Lung Cancer Res. 2020 …
-
HUTCHMED Announces NDA Acceptance in China with Priority Review Status for ORPATHYS® and TAGRISSO® Combination in Lung Cancer Patients with MET amplification After Progression on First-Line EGFR Inhibitor Therapy
02 Jan 2025 00:00 GMT
… -positive non-small cell lung cancer (“NSCLC”) with MET … and Histological Samples in 11. Non-Small Cell Lung Cancer: a … of EGFR TKI-resistant lung cancer. Journal of Hematology … cell lung cancer – A systematic review and meta-analysis. Lung Cancer. 2018 …
-
Expanded Targets, Synergistic Regimens Are Needed to Propel NSCLC Beyond Anti–PD-1 Therapy
02 Feb 2025 04:32 GMT
… with non–small cell lung cancer (NSCLC), identifying … future of immunotherapy in lung cancer, highlighting key trials … IV NSCLC with squamous histology; ARTEMIDE-Lung03 (NCT06627647) … lung cancer: What’s next? Presented at: 22nd Annual Winter Lung Cancer …
About
© 1995-2025